Median OS (months) | p value | ||
---|---|---|---|
Age | <60 | 8.8 | |
≥60 | 7.0 | 0.778 | |
T classification | T3 | 4.9 | |
T4 | 8.9 | 0.120 | |
N classification | N0 | 8.8 | |
N1 | 8.9 | 0.543 | |
Exploratory laparotomy | No | 8.9 | |
Yes | 8.5 | 0.550 | |
Neoadjuvant chemotherapy | No | 8.8 | |
Yes | 6.6 | 0.814 | |
RT dose delivered | <54 Gy | 6.8 | |
≥54 Gy | 11.3 | 0.089 | |
RT modality | IMRT | 8.8 | |
3D | 8.5 | 0.275 | |
Protocol | On | 8.5 | |
Off | 9.0 | 0.123 | |
TNFerade | No | 8.8 | |
Yes | 11.3 | 0.996 | |
CA 19–9 pre-CRT | <90 U/mL | 8.8 | |
≥90 U/mL | 8.8 | 0.626 | |
CA 19–9 post-CRT minimum | <90 U/mL | 12.3 | |
≥90 U/mL | 8.8 | 0.012 |